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Title: Profile of addicted patients who re-enter treatment programmes 
Abstract 
Objective. This study explored the differential profile of addicted patients who re-enter 
treatment programmes.  
Method. A sample of 252 addicted patients (203 male and 49 female) who sought 
outpatient treatment was assessed. Data regarding socio-demographic factors, drug 
consumption factors (assessed using the EuropAsi), psychopathological factors 
(assessed using the Symptom Checklist 90 Revised [SCL-90-R]), and personality 
variables (assessed using the Millon Clinical Multiaxial Inventory II [MCMI-II]) were 
collected.  
Results. 65.9% (n=166) of drug-addicted patients were re-admitted into treatment 
programmes. All of the variables for which we collected data were compared between 
these treatment repeaters and patients who were admitted for the first time. Significant 
differences between the two groups of patients were found for some of the variables that 
we examined. Treatment repeaters were generally older and had a poorer employment 
situation than first-time admits. Treatment repeaters were also more likely to report 
poly-consumption and to have sought treatment for alcohol abuse. Moreover, some of 
the scores for several EuropAsi, SCL-90-R, and MCMI-II variables were statistically 
significantly different from those of the first-time admits.  
Conclusions. According to these results, patients who re-enter treatment programmes 
often present with more severe addiction problems. The implications of these results for 
further research and clinical practice are discussed. 
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Introduction 
Drug addiction is a multidimensional problem that affects all facets of the lives 
of those who suffer from it. Some of the areas that are most seriously affected during 
the course of an addiction are the physical and mental health of the addicted individuals 
as well as their family and social relationships or employment 1-3, although the manner 
in which each individual is affected varies 4. Addiction treatment programmes attempt 
to respond to the needs of patients who fail to overcome periods of drug use by 
themselves, and to the extent that it is possible, these programmes attempt to minimise 
the negative impact that an addiction may have on the lives of their participants. In 
general, an adequate treatment course that is aimed at meeting the needs of a patient 
favours the completion of therapy 5,6. The completion of treatment is one of the best 
predictors of the absence of subsequent relapses 7-9.  
However, clinical experience shows that some patients who suffer from drug 
addiction are re-admitted to treatment programmes multiple times because of relapses 
that occur after they leave these programmes 10. In recent decades, the interest in a 
subtype of patients who, despite receiving treatment, alternate between periods of 
abstinence (or more controlled drug use) and periods of relapse and re-admission into 
treatment programmes has increased 11,12. Scott, Dennis and Foss describe three 
common situations in the recovery process of patients with addictions: relapse, re-entry 
into a treatment programme, and abstinence 13. These authors followed a cohort of 448 
patients for a two-year period, and they found that approximately 1/3 of the patients 
changed from one of these states (relapse, treatment programme re-entry, or abstinence) 
to another every four months; 82% changed at least once during the 2-year period, and 
62% moved between recovery states several times. Similarly, Dennis et al. 14, found that 
over half of the patients who participated in their study had entered into treatment 
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programmes at least twice, and that, on average, each person had received three or four 
therapeutic interventions to obtain a 1-year period of abstinence during an 8-to-9 year 
interval.  
For this reason, some programmes that involve systematic contact with previous 
patients have been developed. In some cases, the aim of this contact is to evaluate the 
conditions of these patients and to provide the patients with care without waiting for the 
patients to demand treatment 11,13,15-17. In other cases, systematic contact is intended to 
offer ongoing support beyond that provided in the actual treatment 18. The results that 
have been found to date are promising. Among other benefits, fewer episodes of use and 
shorter durations of these episodes were found among the subjects who were included in 
these studies. Thus, these patients presented fewer psychological problems and fewer 
risk behaviours for HIV. Moreover, the treatment programmes in which they 
participated were shown to be profitable from an economic standpoint 19. 
It is important to remember, however, that the patients who re-enter treatment 
programmes repeatedly may do so because they have problems or difficulties that were 
not addressed or that were not satisfactorily solved during previous treatment periods. 
Perhaps, then, an effective first intervention may prevent future problems and situations 
in which a patient requires multiple treatment programme re-admissions, which could 
explain the reason that the first admission is a good predictor of therapeutic success in 
some programmes 5.  
Despite the high prevalence of re-admission into treatment programmes, only a 
few studies have examined the general profile of patients who re-enter these 
programmes and the possible differences between re-entering patients and patients who 
respond to first-time treatment; moreover, most of these studies have been conducted on 
patients of Anglo-Saxon ethnic backgrounds. The few studies that have been conducted 
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show that re-admitted patients generally have a more severe profile than those who 
respond to first time treatment. In general, patients who re-enter treatment programmes 
are older and less educated than first-time admits; re-admitted patients also have less job 
stability, more problems with the law, and more medical, psychiatric, and family 
problems than patients who seek treatment for the first time 20-23.  
It is known, however, that one of the best predictors of success is the completion 
of an entire treatment programme. Various studies have suggested that patients who 
abandon treatment prematurely (regardless of the treatment period in question) present 
with, among other factors, more anxiety problems 24, more severe addictions 6,25, greater 
cognitive deficits 26,27, more personality disorders 25,28,  greater psychopathological 
problems 29, less social or familial support, or different combinations of these factors 
4,30. The combination of withdrawal from a previous treatment programme and the 
presence of a more severe addiction profile requires that the protocols that are used in 
the treatment of a re-admitted patient have specific adaptations that are designed to 
make therapeutic interventions more efficient. 
For all of the aforementioned reasons, and keeping in mind the goal of 
understanding the specific characteristics of patients who are admitted into addiction 
treatment programmes more than once, the present study aims to first establish the 
percentage of re-admitted patients in addiction treatment programmes and to then 
evaluate the differences between patients who re-enter treatment programmes and 
patients who seek treatment for the first time. The main hypothesis of the study is that 
those patients who re-enter treatment programs will present a more severe profile of 
addiction. 
Method 
Participants 
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The initial sample consisted of 284 consecutive addicted patients who came to 
the XXXX XXXXX XXXXX de XXXXX (Spain) to obtain outpatient treatment 
between October 2008 and July 2010. This is a cognitive-behavioral intervention on an 
outpatient basis, aimed at abstinence, and it is not required to pay for treatment. The 
main therapeutic techniques are related to stimulus control and in vivo exposure, as well 
as relapse prevention. Successful program completion typically requires around 12 
months, and it is achieved when a patient completes all therapeutic sessions. This 
program has shown effective in the treatment of addictions 25. 
The current study’s admission criteria were that the patients had to a) meet the 
diagnostic criteria of substance dependence according to the DSM-IV-TR (American 
Psychiatric Association, 2000); b) be between 18 and 65 years old; c) give their informed 
consent to participate in the study; and d) complete the three assessment sessions. 
According to these criteria, 252 patients were selected for the study (88.7% of the initial 
sample). The rest of them (32 patients) did not meet the admission criteria for the study.  
The mean age of the individuals included in the study was 37.6 years (SD=9.5); 
the sample included 203 (80.6%) men and 49 (19.4%) women. The socioeconomic level 
was middle to lower-middle class. The main substances that motivated treatment were 
cocaine (49.6% of the sample) and alcohol (43.3% of the sample), followed by other 
substances (e.g., heroin, cannabis, amphetamine, etc.) in smaller numbers (7.1% of the 
sample). 
Assessment measures 
The EuropAsi 31 is the European version of the Addiction Severity Index 32. This 
interview assesses the need for treatment in the following six areas: a) general medical 
state; b) labour and economic situation; c) drug consumption (alcohol included); d) 
legal problems; e) family and social relationships; and f) psychiatric state. Severity 
López-Goñi, J.J., Fernández-Montalvo, J., Cacho-Fernández, R. y Arteaga, A. (2014). 
Profile of addicted patients who re-enter treatment programmes. Substance Abuse, 35, 176-
183. http://www.tandfonline.com/doi/full/10.1080/08897077.2013.826614 
7 
scores range from 0 (no problem) to 9 (extreme problem) in each area, and the cut-off 
point for each area is 4. These areas are directly related to the severity of consumption 4. 
In this study we have also used the “Composite scores” (CS) of the EuropASI. The 
composite scores were developed for research purposes; they are arithmetically-based 
indicators of current (last 30 days) problem severity and range between 0.00–1.00, with 
higher values denoting higher degrees of severity. The composite scores have been 
calculated according to the proposal by Koeter & Hartgers 33. The Spanish version of 
the EuropAsi was developed by Bobes, González, Sáiz and Bousoño 34. The short-term 
test–retest reliabilities of the ASI severity ratings have been reported to be greater than 
or equal to 0.92 for all domains. 
The Symptom Checklist-90-Revised (SCL-90-R) (Derogatis, 1992;35 Spanish 
version by González de Rivera, 2002) 36 is a self-administered general 
psychopathological assessment questionnaire. It consists of 90 questions that are 
answered on a 5-point Likert-type scale, ranging from 0 (none) to 4 (very much). The 
questionnaire aims to assess the respondent’s psychiatric symptoms. The SCL-90-R has 
been shown to be sensitive to therapeutic change, and thus may be used for either single 
or repeated assessments. The SCL-90-R measures nine areas of primary symptoms: 
somatisation, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, 
hostility, phobic anxiety, paranoid ideation and psychoticism. It also provides three 
indices that reflect the subject’s overall level of severity. The internal consistency 
ranges from .70 to .90. 
The Millon Clinical Multiaxial Inventory (MCMI-II) 37 is a self-report 
questionnaire with 175 true/false items. It was designed to identify clinical states and 
personality disorders that are similar to those contained in the DSM-IV-TR. The MCMI-
II contains 10 basic personality scales: 1) Schizoid, 2) Phobic, 3) Dependent, 4) 
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Histrionic, 5) Narcissistic, 6) Antisocial, 7) Aggressive/sadistic, 8) Compulsive, 9) 
Passive-aggressive, and 10) Self-destructive. In addition to the basic personality 
patterns, there are three pathological personality scales: Schizotypal (S), Borderline (B) 
and Paranoid (P). The nine symptom scales of the MCMI-II were not taken into account 
in this study as they are not relevant to the purposes of our research. According to the 
conservative criteria of Weltzer 38 regarding the MCMI-II, a base rate score above 84 for 
the personality scales is considered to be significant for the existence of a personality 
disorder. The internal consistency ranges from .66 to .89. 
Procedure 
The protocol for this study was approved by the ethics committees of the XXX 
XXXX and of the XXX XXX de XXX.  
Once the clinical sample was selected using the previously described criteria, the 
assessment of the sample was carried out in three sessions before beginning the 
treatment. Each session took place once a week for three weeks; the time interval 
between sessions was the same for each participant. In the first session, data related to 
socio-demographic characteristics and drug consumption were collected using the 
EuropAsi. In the second session, the presence of psychopathological symptoms was 
assessed using the SCL-90-R. Finally, in the third session, the prevalence of personality 
disorders was assessed using the MCMI-II. 
After the assessment sessions, patients began the standard treatment of Proyecto 
Hombre for addiction. Detailed tracking treatment history of each subject's was made. 
In this study they were considered as re-admitted patients those who had previous 
treatment experiences, independently of where they had been received, during a 
minimum period of 1 month.  
Data analysis 
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Descriptive analyses were conducted for all variables. Bivariate analyses were 
employed using χ2 or t-test statistics, depending on the nature of the variables studied. A 
difference of p < .05 was considered significant. Statistical analyses were carried out 
using SPSS (version 15.0 for Windows). 
Results 
Of the subjects who participated in the present study, 65.9% had previous 
treatment experiences and were therefore considered re-admitted patients. In contrast, 
34.1% of the patients in the sample (n=86) were being treated for their addictions for 
the first time. Comparisons between the two types of patients regarding various 
sociodemographic variables and substance consumption are shown in Table 1.  
Please insert Table 1 here. 
In general, patients who are receiving treatment for the first time are younger 
and more likely to be employed than those who have received treatment more than 
once. Differences between the groups also exist regarding the particular type of 
substance addiction that resulted in admission. Most first-time patients were admitted 
because of cocaine abuse (67.4%), followed by alcohol abuse (27.9%) and the abuse of 
multiple substances (4.7%). However, re-admitted patients were most often admitted for 
alcohol use (51.2%), then cocaine use (40.4%) and poly-use (8.4%).  
The severity of each patient’s addiction was evaluated using the EuropAsi 
(Table 2), and the patients who had multiple periods of treatment generally presented 
with greater severity than first-time admits in five of the seven areas that were scored by 
an interviewer (medical, employment, alcohol and drug use, legal, family/social and 
psychiatric) and in three of the nine areas that were evaluated by means of the 
composite scores (medical, financial, and family situation). 
Please insert Table 2 here. 
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The entire sample showed moderate-high scores on the Symptom Checklist 90 
Revised (SCL-90-R) (approximately 60th percentile), which was used to assess 
psychopathological symptoms (Table 3). The only significant difference between both 
groups was observed in psychoticism. Patients who had multiple treatment periods 
generally had higher psychoticism scores than those who were receiving treatment for 
the first time. 
Please insert Table 3 here. 
Compared with patients who were receiving treatment for the first time, patients 
with multiple periods of treatment also had higher Millon Clinical Multiaxial Inventory 
II (MCM-II) scores that were indicative of phobic, anti-social, self-destructive, and 
schizotypal personality disorders (see Table 3). However, we did not find any 
categorical differences between the two groups of patients that were statistically 
significant (see Table 4). 
Please insert Table 4 here. 
Finally, there were several differences between the two patient groups regarding 
various adaptation variables (Table 5). Re-admitted patients had significantly greater 
numbers of medical problems, including depression and suicidal ideation, than first-
time admits, and they were more often dissatisfied with their current living situations. 
There was also a significant difference in the income sources of the two patient groups: 
whereas 79.1% of the patients who were in their first admission were employed, only 
59.0% of the re-admitted patients were employed. Thus, a higher proportion of 
members in the latter group was either unemployed or in other situations. Lastly, a 
greater proportion of re-admitted patients indicated that they had not had close friends 
during the courses of their lives.  
Please insert Table 5 here. 
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Discussion 
In the therapeutic programme that was analysed in the present study, two of 
every three patients had received previous treatment for their addictions, which is 
similar to the proportion of readmitted patients previously been found in other (non-
Spanish) contexts 17. From an institutional perspective, this is an alarming finding 
because it implies that a great deal of therapeutic effort is directed towards individuals 
who have already been treated (via one of many possible mechanisms), and it implies 
that, at least to some extent, the treatment failed. In this situation, it is necessary to 
continue to conduct studies that, similar to the present study, will help improve the care 
that is given. This is particularly important because patients with multiple treatment 
periods generally present an addiction profile that is different from and more severe 
than that of patients who are being treated for the first time 22,23.  
The present study highlights the elevated severity of alcohol abuse among 
patients with multiple treatments. In previous studies, the role of alcohol has been 
described as a predictor of treatment withdrawal 39 or relapse 9. However, cocaine is 
often the gateway drug that prompts first treatment. From a clinical perspective, it is 
known that few patients only consume cocaine. Rather, cocaine is often used in 
conjunction with large quantities of alcohol 40. These data present the possibility of 
finding patients who substitute cocaine use with alcohol use, thereby developing an 
alcoholic dependence that later requires another treatment. Another possibility (given 
the size of the standard deviation in the age of the sample) is related to the influence of 
older participants who are known to prefer alcohol as a primary substance due to 
generationally related cultural factors. 
From a psychopathological perspective, re-admitted patients presented more 
severe psychopathology than first-time recipients of addiction therapy, according to 
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several personality scales, including the scales for phobic, antisocial, self-destructive, 
and schizophrenic personalities. In addition, these patients presented with a higher 
proportion of depressive episodes and severe suicidal ideation throughout their lives 
than first-time admits. These data support the particular need of treatment focused on 
psychopathological symptoms simultaneously to the addiction problem among those re-
entering treatment. As a matter of fact, previous studies have shown that all of these 
problems are associated with poor treatment outcomes and high rates of early 
withdrawal from treatment programmes, which in turn are associated with new relapses 
25,28. Thus, it is necessary to develop an early and specific intervention that addresses 
addiction at a psychopathological level and that will prevent early withdrawal from 
treatment programmes.  
Patients with multiple treatments were also observed to have more problems in 
various relational areas than patients who sought treatment for the first time. Compared 
with first-time admits, re-admitted patients generally felt dissatisfied with their current 
living situations; 30% of them did not have close friends, and they had frequently had 
less work activity during the previous 3 years. All of these problems could be related to 
repeated relapses in substance use, which in turn make obtaining the necessary support 
to remain abstinent difficult. The familial and social relationships of addiction patients 
are severely affected during periods of substance abuse, which makes supporting the 
patient difficult 1. Social and family problems are frequent in drug abusers. The 
relationship between both problems can be bidirectional. In some cases it is a direct 
consequence of drug abuse, which isolates the affected patients. In other cases, 
consumption is a way to cope the social and family isolation. 
All of the aforementioned problems could create a vicious cycle that makes 
therapeutic intervention difficult, particularly given that patients only seek treatment 
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when they are having serious problems. Some interventions that have been developed in 
recent years may improve the access to treatment and thereby improve the results of 
subsequent treatments because they prevent the further deterioration of the patient. For 
example, some of the proposals that have been developed in recent years focus on 
treatment programmes that include reaching out to patients and inquiring about their 
situations 16,17 or extending the care of a patient over time 18. 
The problems with treatment compliance that were observed in the present study 
are not unique to patients with addictions. It is estimated that 20 to 40% of chronic 
patients fail to follow the medical recommendations that have been made to them and 
that dysfunctional social support is detrimental for treatment adherence and may result 
in withdrawal from treatment 41. This similarity allows for a search for interventions for 
addiction to be conducted via the review of successful interventions that have been 
observed in areas other than addiction 
Several limitations of the present study must be taken into consideration. The 
first is related to the sample that was evaluated. Although our study included a relatively 
large sample of patients who were being treated for drug abuse, it was composed of 
patients who sought treatment for the use of a variety of substances. In addition, only 
19.4% of the sample comprised women. There are reasons to believe that women who 
suffer from drug addictions have problems different from those of addicted men. The 
general profile of women who are participating in treatment programmes is more severe 
than the profile of men in these programmes, but women also tend to have a better 
prognosis 5. Moreover, the present study only included patients who had finished the 
assessment; patients who did not complete the three assessment sessions were not 
considered. We assume that patients who withdraw from a treatment programme at an 
early stage have profiles that are different from those of the patients who were analysed 
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in this study. On the other hand, this study did not take into account neither 
characteristics of previous treatments in re-admitted patients, nor time elapsed since the 
beginning of the consumption until the arrival to treatment. These variables could affect 
the differences found. For all of these reasons, we must be cautious when attempting to 
generalise our results. 
In the future, it would be interesting to conduct follow-up studies regarding the 
predictive validity of prior treatment admission with respect to relapses after the 
completion of an entire treatment programme. Ultimately, the main goal of a treatment 
programme should be the recovery of the patients who participate in it, not their 
fulfilment. 
In conclusion, the results of this study show that patients with multiple treatment 
periods generally have more severe problems than patients who are first-time admits. 
Previous studies have shown that patients with more severe or numerous problems are 
more likely to withdraw from treatment 25. All of these data suggest that at least two 
types of improvements must be included in future treatment protocols: (1) treatment 
programmes should incorporate a detailed analysis regarding the existence and nature of 
prior treatments into the baseline protocols that are used for the evaluation of addiction 
patients 12; and (2) treatment programmes should offer follow-up services to patients 
who have completed their treatments 11,18. 
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Table 1. Comparisons in socio-demographic and drug abuse characteristics 
 
 All N= 252 
Readmitted 
patients  
(n = 166) 
First-time 
admits 
(n = 86) 
 
 Mean (SD) Mean (SD) Mean (SD) t (df) 
        
Mean age 37.6 (9.5) 38.6 (9.5) 35.5 (9.1) 2.4 (250)* 
        
 N (%) n (%) n (%) X2  (df) 
Sex        
Men 203 (80.6%) 136 (81.9%) 67 (77.9%) 
0.6 (1) 
Women 49 (19.4%) 30 (18.1%) 19 (22.1%) 
        
Marital Status        
Single 122 (48.4%) 72 (43.4%) 50 (58.1%) 
5.5 (3) 
Married 76 (30.2%) 53 (31.9%) 23 (26.7%) 
Divorced 50 (19.8%) 38 (22.9%) 12 (14.0%) 
Widower 4 (1.6%) 3 (1.8%) 1 (1.2%) 
        
Education   (n = 165) (n = 86)  
None 28 (11.2%) 20 (12.1%) 8 (9.3%) 
7.3 (3) 
Primary school 135 (53.8%) 93 (56.4%) 42 (48.8%) 
Secondary school 62 (24.7%) 41 (24.8%) 21 (24.4%) 
University 26 (10.4%) 11 (6.7%) 15 (17.4%) 
        
Employment situation   (n = 166) (n = 86)  
Employed 166 (65.9%) 98 (59.0%) 68 (79.1%) 
11.7 (2)** Unemployed 68 (27.0%) 56 (33.7%) 12 (14.0%) 
Others (student. retired. etc.) 18 (7.1%) 12 (7.2%) 6 (7.0%) 
        
Substance that motivated treatment        
Alcohol 109 (43.3%) 85 (51.2%) 24 (27.9%) 
16.6 (2)*** Cocaine 125 (49.6%) 67 (40.4%) 58 (67.4%) 
Others (heroin. cannabis…) 18 (7.1%) 14 (8.4%) 4 (4.7%) 
        
Poly-consumption 64 (25.4%) 49 (29.5%) 15 (17.4%) 4.4 (1)* 
        
Drug overdose 29 (11.5%) 23 (13.8%) 6 (7.0%) 2.6 (1) 
        
 
*p < .05; **p < .01; ***p < .001 
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Table 2. Comparisons in drug addiction severity variables 
 
 
 All (N = 252) 
Readmitted 
patients 
(n = 166) 
First-time 
admits 
(n = 86) 
  
 M (SD) M (SD) M (SD) t df 
EuropASI (ISR)      
Medical 2.0 (1.4) 2.2 (1.5) 1.5 (1.0) 4.1*** 250 
Employment/Support 2.4 (1.7) 2.7 (1.8) 1.8 (1.3) 3.9*** 250 
Alcohol use 3.9 (2.0) 4.3 (2.0) 3.1 (1.7) 4.9*** 250 
Drugs use 3.4 (2.1) 3.4 (2.3) 3.4 (1.6) 0.1 249 
Legal 1.8 (1.5) 1.9 (1.6) 1.6 (1.0) 1.5 250 
Family/Social 3.7 (1.7) 4.0 (1.8) 3.1 (1.4) 3.9*** 249 
Psychiatric 3.2 (1.7) 3.5 (1.8) 2.8 (1.5) 3.2** 250 
      
EuropASI (CS) M (SD) M (SD) M (SD) t df 
Medical .22 (.25) .25 (.26) .16 (.23) 2.9** 250 
Economic situation .38 (.45) .46 (.46) .23 (.40) 3.9*** 250 
Labour satisfaction .27 (.32) .30 (.32) .22 (.33) 1.7 250 
Alcohol .31 (.24) .32 (.23) .31 (.25) 0.3 250 
Drug use .13 (.12) .11 (.12) .16 (.11) 2.1* 250 
Legal .12 (.21) .12 (.21) .12 (.21) 0.1 249 
Family .27 (.23) .29 (.23) .23 (.24) 2.0* 250 
Others  .15 (.18) .16 (.18) .13 (.18) 1.0 248 
Psychiatric .21 (.19) .22 (.20) .19 (.16) 1.2 242 
ISR = Interviewer Severity Ratings 
CS = Composite Scores 
*p < .05; **p < .01; ***p < .001 
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Table 3. Comparisons in clinical variables 
 
 All (N = 252) 
Readmitted 
patients  
(n = 166) 
First-time 
admits  
(n = 86) 
  
 M (SD) M (SD) M (SD) t df 
SCL-90-R (percentiles)      
Global Severity Index 64.6 (33.0) 66.7 (32.4) 60.5 (33.9) 1.4 250 
Positive Symptom Distress Index 46.6 (31.7) 47.4 (31.7) 45.1 (31.9) 0.5 250 
Positive Symptom Total 69.0 (31.6) 70.8 (31.0) 65.4 (32.7) 1.2 250 
Somatisation 57.8 (32.2) 58.2 (32.3) 57.1 (32.3) 0.2 250 
Obsessive-compulsive 61.9 (32.8) 64.1 (31.8) 57.6 (34.4) 1.5 250 
Interpersonal sensitivity 63.1 (33.3) 65.9 (32.1) 57.8 (35.1) 1.8 250 
Depression 60.2 (33.1) 62.7 (32.6) 55.3 (33.8) 1.7 250 
Anxiety 57.1 (33.7) 57.8 (34.1) 55.6 (33.0) 0.5 250 
Hostility 52.5 (33.2) 52.3 (33.2) 53.0 (33.4) 0.2 250 
Phobic anxiety 52.2 (36.8) 54.3 (36.7) 48.1 (36.9) 1.3 250 
Paranoid ideation 61.8 (33.0) 66.7 (32.4) 60.5 (33.9) 1.2 250 
Psychoticism 68.2 (33.0) 71.2 (31.7) 61.1 (34.5) 2.5* 250 
MCMI-II      
Schizoid 58.1 (27.8) 59.5 (29.6) 55.4 (23.9) 1.1 250 
Phobic 49.3 (27.9) 52.3 (27.4) 43.7 (28.1) 2.3* 250 
Dependence 59.9 (24.2) 61.3 (23.5) 57.0 (25.3) 1.3 250 
Histrionic 54.2 (20.2) 54.7 (19.6) 53.2 (21.3) 0.6 250 
Narcissistic 50.7 (23.6) 51.5 (22.9) 49.2 (25.0) 0.7 250 
Antisocial 53.2 (23.4) 56.0 (22.8) 47.9 (23.9) 2.6** 250 
Aggressive–sadistic 52.5 (22.7) 53.7 (22.6) 50.1 (23.0) 1.2 250 
Compulsive 54.2 (21.0) 54.0 (21.6) 54.5 (20.0) 0.2 250 
Passive–aggressive 45.3 (30.5) 46.5 (31.3) 42.8 (28.9) 0.9 250 
Self–destructive 48.0 (24.2) 51.1 (23.3) 42.2 (24.9) 2.8** 250 
Schizotypal 41.8 (23.3) 44.1 (23.4) 37.4 (22.5) 2.2* 250 
Borderline 39.5 (25.9) 41.6 (25.5) 35.5 (26.4) 1.8 250 
Paranoid 56.0 (16.7) 57.1 (16.3) 53.9 (17.2) 1.5 250 
 
*p < .05; **p < .01 
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Table 4. Comparison in the rate of personality disorders 
 
 
All 
 
(N = 252) 
Readmitted 
patients 
(n = 166) 
First-time 
admits 
(n = 86) 
 
MCMI-II N (%) n (%) n (%) X2 (df) 
Schizoid 23 (9.1%) 17 (10.2%) 6 (7.0%) 0.7 (1) 
Phobic 19 (7.5%) 15 (9.0%) 4 (4.7%) 1.6 (1) 
Dependence 29 (11.5%) 21 (12.7%) 8 (9.3%) 0.6 (1) 
Histrionic 7 (2.8%) 6 (3.6%) 1 (1.2%) 1.3 (1) 
Narcissistic 17 (6.7%) 11 (6.6%) 6 (7.0%) 0.0 (1) 
Antisocial 18 (7.1%) 15 (9.0%) 3 (3.5%) 2.6 (1) 
Aggressive–sadistic 21 (8.3%) 16 (9.6%) 5 (5.8%) 1.1 (1) 
Compulsive 18 (7.1%) 12 (7.2%) 6 (7.0%) 0.0 (1) 
Passive–aggressive 28 (11.1%) 18 (10.8%) 10 (11.6%) 0.0 (1) 
Self–destructive 12 (4.8%) 9 (5.4%) 3 (3.5%) 0.5 (1) 
Schizotypal 6 (2.4%) 5 (3.0%) 1 (1.2%) 0.8 (1) 
Borderline 6 (2.4%) 5 (3.0%) 1 (1.2%) 0.8 (1) 
Paranoid 6 (2.4%) 6 (3.6%) 0 (0.0%) 3.2 (1) 
TOTAL1 118 (46.8%) 82 (49.4%) 36 (41.9%) 1.3 (1) 
 
*p < .05 
 
1The total number of people affected by personality disorders is inferior to the total sum of disorders 
because there are patients who present more than one personality disorder. 
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Table 5. Comparison of maladjustment variables 
 
  
 
 
N 
All 
(N = 252) 
Readmitted 
patients 
(n = 166) 
First-time 
admits 
(n = 86) 
 
N   (%) n   (%) n   (%) X2 (df) 
Medical problems      
Infected with hepatitis 248 48 (19.4%) 38 (22.9%) 10 (11.6%) 4.5* (1) 
Family maladjustment      
Problems with the patient’s 
Mother 249 75 (30.1%) 47 (28.7%) 28 (32.9%) 0.5 (1) 
Father 242 86 (35.7%) 57 (35.4%) 29 (36.3%) 0.0 (1) 
Brother(s)/sister(s) 241 79 (32.8%) 53 (33.1%) 26 (32.1%) 0.0 (1) 
Sexual partner 239 146 (61.1%) 102 (64.6%) 44 (54.3%) 2.4 (1) 
Son(s)/daughter(s) 120 15 (12.5%) 11 (12.5%) 4 (12.5%) 0.0 (1) 
Satisfaction with the typical 
living arrangement 
Yes  156 (62.2%) 96 (58.2%) 60 (69.8%)  
No 251 63 (25.1%) 50 (30.3%) 13 (15.1%) 7.9* (2) 
Indifferent  32 (12.7%) 19 (11.5%) 13 (15.1%)  
      
Social maladjustment      
Lacking close friends 252 66 (26.2%) 51 (30.7%) 15 (17.4%) 5.2* 
Problems with the patient’s 
Close friends 177a 63 (35.6%) 34 (29.6%) 29 (40.8%) 2.5 (1) 
Neighbours 248 31 (12.5%) 22 (13.4%) 9 (10.7%) 0.4 (1) 
Work colleagues 249 71 (28.6%) 49 (29.9%) 22 (26.2%) 0.4 (1) 
      
Labour maladjustment      
Lacking a permanent job  
during the previous 3 years 252 38 (15.1%) 28 (16.8%) 10 (11.8%) 1.2 (1) 
Main income source 
Employment  158 (62.7%) 93 (56.0%) 65 (75.6%)  
Colleagues  
and/or relatives 252 37 (14.7%) 30 (18.1%) 7 (8.1%) 10.7* (3) 
Social services  42 (16.7%) 30 (18.1%) 12 (14.0%)  
Illegal  15 (5.9%) 13 (7.8%) 2 (2.3%)  
Psychiatric maladjustment      
Depression 252 131 (52.0%) 96 (57.8%) 35 (40.7%) 6.7** (1) 
Suicidal ideation 252 100 (39.7%) 74 (45.6%) 26 (30.2%) 4.9* (1) 
 
*p < .05;**p < .01 
 
 
